Brin's been researching Botox since 1984 and is currently the chief scientific officer of Botox at the drug company Allergan. It's one of many Botox-related license plates he owns, including some ...

It was then that Actavis, a drug company that specializes in generic drugs and over-the-counter products, scooped up Allergan for a neat $66 billion. Here's a photo of Actavis CEO Brenton Saunders ...

Class will soon be in session at the Allergan Aesthetics headquarters. The AbbVie brand plans to open doors at its headquarters in Irvine, Calif., to offer an immersive training center for health care ...

The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash. The portfolio in question consists of four acne products that are already on the market ...

with Dublin-based Allergan, which has been struggling in the face of competition for some of its biggest products including the wrinkle-smoothing treatment Botox. It's the first major acquisition ...